Preset Insider Trade Ideas Penny Stock Buys Insider Trading All Insider Purchases All Insider Sales All Insider Purchases Above 25K Officer Sales Above 25K CEO/CFO Sales Above 25K Insider Purchases Today Insider Purchases Past Week Insider Purchases Past Month Officer Purchases Today Officer Purchases Past Week Officer Purchases Past Month Officer Purchases Past Week Officer Purchases Past Month Insider Sales Today Insider Sales Past Week Insider Sales Past Month Officer Sales Today Officer Sales Past Week
OrbiMed Capital GP VIII LLC's Net Worth $0
Estimate Recalculated Jan 4, 2025 01:02AM EST
Who is OrbiMed Capital GP VIII LLC OrbiMed Capital GP VIII LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Janux Therapeutics, Inc., Decibel Therapeutics, Inc., Kinnate Biopharma Inc., Disc Medicine, Inc., and Traws Pharma, Inc..
SEC CIK OrbiMed Capital GP VIII LLC's CIK is 0001845804
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. Investor
Updated Jan 31, 2024
Janux Therapeutics, Inc. Investor
Updated Dec 30, 2021
Decibel Therapeutics, Inc. Investor
Updated Feb 19, 2021
Kinnate Biopharma Inc. Investor
Updated Apr 05, 2024
Disc Medicine, Inc. Investor
Updated Jun 20, 2024
Traws Pharma, Inc. Investor
Updated Apr 12, 2024
Upstream Bio, Inc. Investor
Updated Oct 17, 2024
Lomond Therapeutics Holdings, Inc. Investor
Updated Nov 05, 2024